Clinical Trial Update: Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC) [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating temozolomide alone or in combination with olaparib for triple-negative breast cancer, which is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Olaparib (Olaparib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Breast Cancer Triple Negative | Phase 2 | Status: NOT_YET_RECRUITING